Theme: Recent Advancements of Medical Care in Diabetes
Euro Diabetes Expo 2015
OMICS International invites Diabetes expertise, researchers, professors, scientific communities, therapists, counselors, delegates, students, business professionals and executives to attend the 8th Euro Global Diabetes Summit and Medicare Expo which is going to be held on November 03-05, 2015 at Valencia, Spain. OMICS International Organizes organizes 1000+ Global events inclusive of 300+ Conferences every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 500+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more conferences, please visit Conference Series
Prevalence of diabetes is increasing among all ages in Europe, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. There are about 60 million people with diabetes in the European Region, or about 10.3% of men and 9.6% of women aged 25 years and over.
Worldwide, high blood glucose kills about 3.4 million people annually. Almost 80% of these deaths occur in low- and middle-income countries, and almost half are people aged less than 70 years. WHO projects diabetes deaths will double between 2005 and 2030.
Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. Patients with high blood sugar will typically experience frequent urination, they will become increasingly thirsty and hungry .The term diabetes mellitus describes several diseases of abnormal carbohydrate metabolism that are characterized by hyperglycemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of peripheral resistance to the action of insulin. They are derived after doing many clinical trials on animal models. Every few years, the diabetes community reevaluates the current recommendations for the classification, diagnosis, and screening of diabetes, reflecting new information from research and clinical practice which in turns help in understanding current prevention and treatment options and cost effectiveness in treatment and prevention of Diabetes. People with type1 and type2 diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the Macro vascular (Coronary artery diseases, cardiomyopathy and stroke) and micro vascular (Retinopathy, neuropathy and nephropathy) complications. In addition, people with diabetes also have a higher risk of developing infections. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation. Maintaining blood glucose levels, blood pressure, and cholesterol at or close to normal can help delay or prevent diabetes complications. Hypoglycemia and Hyperglycemia are the other two factors are the two major complications of diabetes where hyperglycemia is an acute complication sharing many symptoms and hypoglycemia is an acute complication of several diabetes treatments. Glycosylated hemoglobin is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.
Track 2: Genetics of Diabetes
Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes (e.g., maturity-onset diabetes of the young), the majority of genetic risk of diabetes (for type 1 and type 2) remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies. Diabetic amyotrophy is a disabling illness that is distinct from other forms of diabetic neuropathy.
Endocrinology is the study of hormones and the treatment of hormone based diseases. The endocrine glands produce chemicals called hormones. These hormones are released into the blood stream and exert their action by stimulating other organs in the body. However, Clinical trials on endocrinology look at new ways to prevent, detect, or treat disease. The major endocrine glands are the thyroid, pancreas, parathyroid, adrenal, gonad and pituitary. The hormones from these glands regulate growth, metabolism, blood pressure, reproduction as well as many other necessary functions. Early Diagnosis and Treatment of Endocrine Disorders, written by a distinguished panel of clinical experts and research scientists, focuses on the early signs and symptoms of common endocrine diseases, surveys the clinical testing needed for a diagnosis, and concisely presents the best current recommendations for therapy. Pediatric endocrinology is a medical subspecialty that studies and treats conditions affecting physical growth and sexual development in children, as well as diabetes and other disorders of the endocrine (hormone) glands.
The concept of 'new technologies' for type 1 diabetes and new discovery and emerging therapies in type 2 diabetes has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace (e.g. insulin pumps, rapid HbA1c monitoring, etc come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed (e.g. the Glucowatch), regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.
Track 5: Diabetes Management
The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment. Healthy eating is a cornerstone of healthy living — with or without diabetes. But if you have diabetes, you need to know Impact of Food and Nutrition, impact of physical activity and yoga therapy in Diabetes Management. Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. Standards of medical care in Diabetes increased when compared to previous year.
Track 6: Emerging Focus in Diabetes Research
Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned. Diabesity can be defined as a metabolic dysfunction that ranges from mild blood sugar imbalance to full-fledged type 2 diabetes. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal.
Track 7: Transplantation of Diabetes
Getting a new heart, liver, kidney, lung, or other organ can save your life. Sometimes, it can also lead to type 2 diabetes. Many people can stop taking steroids after 6 months or so. This may solve the problem. If scientists can develop safe immunosuppressant’s that always work, then many people with type 1 diabetes may choose to have pancreas transplants. Until then, many doctors think islet transplants are a better option even after performing clinical trials on islet transplants . Islets are clusters of cells in the pancreas that make insulin. In people with type 1 diabetes, islet cells are destroyed. Only 1-2% of the pancreas is made up of islet cells. In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin. A transplant of the pancreas is usually reserved for those with serious complications. Pancreas transplants are most often done when a patient also receives a new kidney. The pancreas transplant adds little further risk in this situation and offers big benefits. However, transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks. Xenotransplantation for the treatment of type 1 diabetes is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. Bolus insulin needs to act quickly and so short acting insulin or rapid acting insulin will be used where as Conventional insulinotherapy is a therapeutic regimen for treatment of diabetes mellitus which contrasts with the newer intensive insulin therapy.
Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction
Track 9: Computational Biology of Diabetes
Computational meta-analysis can link environmental chemicals to genes and proteins involved in human diseases, thereby elucidating possible etiologies. The recent rapid development of a variety of analytical platforms based on mass spectrometry and nuclear magnetic resonance have enabled identification of complex metabolic Syndrome phenotypes. Continued development of bioinformatics and analytical strategies has facilitated the discovery of causal links in understanding the pathophysiology of diabetes and its complications
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.
Diabetes mellitus, commonly referred to as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications include diabetic ketoacidosis and non ketotic hyperosmolar coma. Serious long-term complications include cardiovascular disease, stroke, chronic kidney failure, foot ulcers, and damage to the eyes. Diabetes is a way to carefully test a new drug or device in patients before it is approved by the FDA to be used in the general public.
Diabetes Clinical trials are an important step in our being able to have new treatments for diabetes and other conditions. Clinical trials offer the opportunity to play an active role in their own health care and to access potential new treatments before they are widely available.
Omics International Diabetes conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research. These Diabetes Meeting aims in reaching the most advanced research in diabetes, as the Nation's largest congregation point for diabetes researchers and experts. Our Diabetes conventions delivers the most advanced research and gives you an unforgettable experience in your life. Euro Diabetes Conference aims to provide opportunity and to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere.
Young Researcher Sessions are organized at the Euro Diabetes Conference to provide a unique platform for young researcher/investigators for presenting latest research projects with an in-depth analysis. The use of “diabetes guidelines” or “diabetes algorithm” as search terms will yield greater than 8,900 and 3,100 citations, respectively. European Diabetes Guidelines aim to present all the relevant evidence on a particular clinical issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical medical decision- making. In 1999, the European Association for the Study of Diabetes (EASD) increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD). The Foundation is closely related to the EASD; it is governed exclusively by the Executive Committee of the EASD, which itself is under the close supervision of the EASD Council and the General Assembly of the EASD. On the other hand Endocrinology which is closely related to diabetes is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. The European congress of Endocrinology is an organization established to promote endocrinology in Europe. Diabetes Expo which is a large International Exhibition carries the main agenda of joining the people and experts related to diabetes from different countries. Prevalence of Diabetes is increasing among all ages in Europe, mostly due to increase in over weight and obesity, unhealthy diet and physical inactivity. There are about 60 Million people with diabetes in the European region, or about 10.3% of men and 9.6% of women aged 25 years and over. European diabetes congress aims in updating the recent and most advanced research developments that has taken place in the field of Diabetes. A wide number of diabetes congress are conducted all over the world to create awareness among the people about the new inventions, discoveries and techniques to overcome the diabetes. This Diabetes Exhibitions gives a strong commitment to advance the overall quality of our research activities in the field of diabetes and achieve even greater penetration in the diagnostics and management of patients with suspected or proven disease. European Diabetes Conference attendees leave the meeting feeling inspired and exhilarated to continue and improve our own clinical and research practice, with improved knowledge on most innovative technology and original advances in diabetes therapy and management. European Diabetes conference helps all young students and student communities to meet diabetes experts around the world. Diabetes Association plays a vital role in improving and updating the knowledge on diabetes recent research and advancements. All over the world, World Diabetes Conference are playing a very important role in advancing the research and improving the quality of research.
- Complications associated with diabetes
- Genetics of Diabetes
- Alternative Treatment for Diabetes
- Advanced Technologies for Treatment of Diabetes
- Diabetes Management
- Emerging Focus in Diabetes Research
- Transplantation for Diabetes
- Diabetes Research in Clinical Practice
- Computational Biology of Diabetes
- Risk Factors Related to Diabetes
To share your views and research, please click here to register for the Conference.